DYRK1A and Dravet syndrome: In summary, we have demonstrated that compound 5a is a potent, non-toxic inhibitor of DYRK1A whose metabolic stability in plasma and ability to cross the blood-brain barrier translates into cognitive rescuing effects in a mouse model of DS.